Rationale and design of the HINODE study: Heart failure indication and sudden cardiac death prevention trial Japan.
Hiro YamasakiKenji AndoTakanori IkedaTakeshi MitsuhashiToyoaki MuroharaNobuhiro NishiiAkihiko NogamiYasushi SakataWataru ShimizuTorri SimonCaroline BeaudointTorsten KayserValentina KutyifaKazutaka AonumaPublished in: Journal of arrhythmia (2021)
The Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan is a large prospective multicenter registry with defined device treatment cohorts and will provide data for risk stratification for cardiovascular events in Japanese HF patients.
Keyphrases
- heart failure
- cardiovascular events
- end stage renal disease
- coronary artery disease
- study protocol
- clinical trial
- phase iii
- acute heart failure
- chronic kidney disease
- ejection fraction
- cardiovascular disease
- phase ii
- left ventricular
- peritoneal dialysis
- atrial fibrillation
- prognostic factors
- cardiac resynchronization therapy
- randomized controlled trial
- electronic health record
- machine learning
- big data
- open label
- artificial intelligence
- deep learning
- combination therapy
- replacement therapy
- data analysis